Filter Results:
(96)
Show Results For
- All HBS Web
(635)
- People (4)
- News (96)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Show Results For
- All HBS Web
(635)
- People (4)
- News (96)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Sort by
- 01 Jun 2024
- News
Quantum Leap
pharmaceutical and chemical industries have taken note: The venture capital arm of the pharma giant Merck, for instance, invested $5 million in SEEQC’s Series A round, where it was joined by the South Korean chemical View Details
- 01 Sep 2023
- News
Research Brief: Making Way for Moonshots
Josh Krieger (Courtesy subject) Josh Krieger (Courtesy subject) Many innovations in modern medicine have come about due to cutting-edge drugs—advances that required both a scientific leap and a willingness to take risks. And while most pharmaceutical companies would... View Details
Keywords: Jen McFarland Flint
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but... View Details
- 01 Feb 1999
- News
Too Much of a Good Thing?
layoffs and lost revenues, for example - weak companies are artificially supported," he explains. "Other firms won't or can't restructure themselves or exit unprofitable businesses because they are too set in their ways, lack sound... View Details
Keywords: Garry Emmons
- 01 Jun 2023
- News
From Big Pharma to Startup
pharmaceutical giant one day—not creating a company from scratch. But Goble was determined to explore the wide variety of opportunities available to him in his time at HBS, so when he read about a nonprofit... View Details
Keywords: April White
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
ending up with huge medical bills we couldn’t pay.” Inspired by this personal experience, Rabah chose to build a career in health care. She studied biology as an undergraduate at Cornell, where she developed a strong interest in drug pricing and View Details
- 01 Oct 2001
- News
Guy de Chazal: Changing Focus
putting too much faith in innovative companies with exciting ideas but untried management. "At Morgan Stanley, we're back to basics: We look for young companies that have the advantage of entering a... View Details
Keywords: Deborah Blagg
- 31 Jan 2014
- News
Body, Heal Thyself
BANCEL Throughout 2009 and 2010, Stéphane Bancel (MBA 2000) had received upward of 20 calls from biotech companies asking him to come aboard and lead the company. It made sense. He was a highly recruited CEO successfully running... View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
Known for understanding opportunities ahead of the curve, Ajay Piramal (AMP 110, 1992) led his family’s business away from textiles to pharmaceuticals in the 1980s. “Our guiding principle has been to build businesses that deliver... View Details
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift from the worldwide View Details
Keywords: Anne Kavanagh
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva View Details
- 24 Apr 2014
- News
A passion for the sea doubles the percent of ocean set aside for conservation
Ernesto Bertarelli (MBA 1993), an America’s Cup–winning sailor and avid scuba diver, understands the importance of protecting marine ecosystems. The former owner and CEO of the pharmaceutical and biotechnology View Details
- 15 Dec 2024
- News
After Ozempic
these drugs, known as GLP-1 agonists, amounts to so much more than media buzz. In just a few years, they have ignited a wave of change that has transformed Novo Nordisk into Europe’s most valuable public company. The seismic shift is on track to continue reshaping the... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical View Details
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He... View Details
- 08 Jun 2021
- News
New Funding for Female Founders
Boost VC, SV Angel, Village Global, and Threshold Ventures, according to the Wall Street Journal. Coravos is co-founder and CEO of the startup, formerly known as Elektra Labs, which helps hospitals and pharmaceutical View Details
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
TikToks, comedy-infused content, immersion in pop culture, and one-for-one donation program, the company is ensuring Julie is an essential part of every woman’s medicine cabinet. “Only 17 states require sex-ed to be medically accurate.... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
expected to work for a big company like Kodak for my entire career." Arthur D. Little, 1968-76 Becton, Dickinson and Co., 1976-94 Why HBS? "I learned that an engineer whose desk was close to mine at Kodak had been accepted by the School.... View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details